RBP4: A Versatile Biomarker for Disease Diagnosis and ANT BIO PTE. LTD.'s Antibody Solutions

1. Concept: Retinol-Binding Protein 4 (RBP4)

Retinol-Binding Protein 4 (RBP4) is a member of the lipocalin family and serves as the specific transport protein for lipophilic vitamin A (retinol) in the bloodstream. Predominantly expressed in adipocytes and hepatocytes, human RBP4 consists of 201 amino acid residues and three pairs of disulfide bonds, with its structure elucidated via X-ray crystallography. The structural core of RBP4 features a typical β-barrel motif that specifically accommodates a retinol molecule, rendering this hydrophobic vitamin soluble in aqueous environments and enabling its systemic transport.

RBP4 plays a central role in vitamin A homeostasis through the "RBP4 cycle"—the primary mechanism for distributing vitamin A from hepatic storage to extrahepatic tissues. Beyond its vitamin transport function, RBP4 is closely linked to the pathogenesis of multiple diseases, making it a valuable biomarker in clinical diagnostics and biomedical research.

2. Research Frontiers of RBP4 in Disease Biology

Contemporary research on RBP4 focuses on expanding its diagnostic utility and uncovering novel mechanistic roles. A key frontier is the validation of RBP4 as a multi-disease biomarker, with studies exploring its potential in early detection of chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD). Another prominent direction involves investigating RBP4’s role in metabolic syndrome, particularly its cross-talk with insulin signaling pathways and the gut-liver-adipose axis. Additionally, advancements in detection technology—such as high-sensitivity antibody-based assays—are enhancing the accuracy of RBP4 quantification, enabling its use in personalized medicine and population-based screening . Furthermore, genetic studies are identifying RBP4 variants associated with disease susceptibility, providing insights into genotype-phenotype correlations and potential therapeutic targets .

3. Research Significance of RBP4

The study of RBP4 holds profound implications for both basic science and clinical practice:

• Multi-disease diagnostic value: RBP4 serves as a sensitive marker for renal tubular injury, hepatic dysfunction, insulin resistance, cardiovascular disease, and vitamin A deficiency, addressing unmet needs in early detection and differential diagnosis.
• Prognostic utility: Serum RBP4 levels correlate with disease severity and progression in conditions like cirrhosis and heart failure, guiding treatment optimization and follow-up strategies.
• Mechanistic insights: Research on RBP4’s role in inflammation, metabolic regulation, and embryonic development provides a foundation for developing novel therapies for metabolic and degenerative diseases.
• Nutritional assessment: RBP4 enables accurate evaluation of vitamin A status, critical for maternal and child health and preventing developmental abnormalities.
• Translational potential: As a validated biomarker, RBP4 facilitates the development of point-of-care diagnostic tools, improving access to timely disease screening globally .

4. Relevant Mechanisms, Research Methods and Product Applications

4.1 Core Mechanisms of RBP4 in Health and Disease

Vitamin A Transport and Homeostasis

In the liver, vitamin A is stored as retinyl esters in hepatic stellate cells via LRAT (lecithin retinol acyltransferase)-mediated acylation. Upon hydrolysis by retinyl ester hydrolase (REH), retinol binds to RBP4 in hepatocytes and forms a complex with transthyretin (TTR) to prevent renal filtration. This retinol/RBP4/TTR complex circulates in the bloodstream and delivers retinol to target cells via binding to the membrane receptor STRA6. Hepatocytes also express STRA6 to mediate retrograde retinol transport, maintaining systemic vitamin A balance.

Disease-Associated Mechanisms

• Renal diseases: Impaired glomerular filtration and tubular reabsorption in CKD lead to elevated serum and urinary RBP4 levels, with concentrations correlating with disease severity .
• Hepatic diseases: Liver damage reduces RBP4 synthesis, reflecting impaired hepatic function. RBP4 levels predict steatosis in hepatitis C infection and aid in distinguishing cirrhosis from hepatorenal syndrome .
• Insulin resistance: RBP4 activates CD206+ macrophages, inducing pro-inflammatory cytokine secretion and disrupting insulin signaling. It also upregulates hepatic gluconeogenic enzymes, increasing blood glucose levels.
• Cardiovascular diseases: RBP4 promotes endothelial inflammation and vascular smooth muscle cell proliferation, contributing to atherosclerosis and hypertension. Elevated levels correlate with coronary artery disease risk .
• Developmental disorders: RBP4 deficiency or mutations impair vitamin A delivery to the retina and embryo, leading to night blindness, retinal dysplasia, and congenital malformations (e.g., microphthalmia, exencephaly).

4.2 Key Research Methods for RBP4 Detection

Research and clinical applications of RBP4 rely on sensitive and specific quantification techniques:

• Antibody-based assays: ELISA (Enzyme-Linked Immunosorbent Assay) is the gold standard for RBP4 quantification, utilizing high-specificity antibodies for accurate detection in serum, urine, and tissue samples.
• Western blot: Enables qualitative and semi-quantitative analysis of RBP4 protein expression in cell lysates and tissue homogenates.
• Immunohistochemistry (IHC): Visualizes RBP4 localization in tissues, supporting mechanistic studies on its cellular distribution and function.
• Genetic analysis: PCR and next-generation sequencing (NGS) identify RBP4 variants associated with disease susceptibility .
• Mass spectrometry: Provides high-resolution quantification of RBP4 and its post-translational modifications, aiding in biomarker validation .

4.3 Product Applications of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. delivers high-performance antibody solutions for RBP4 research and diagnostics through its Starter sub-brand—specializing in recombinant antibodies. All products are developed using advanced recombinant rabbit monoclonal antibody platforms, validated for sensitivity and specificity, and comply with EU 98/79/EC, ISO9001, and ISO13485 certifications. Key offerings include:

• RBP4 Recombinant Rabbit mAbs: Catalog numbers S0B3249 (SDT-693-108) and S0B3248 (SDT-693-111) form a high-sensitivity antibody pair with exceptional performance. Validated on downstream chromatography platforms, the antibodies demonstrate >95% correlation with clinical samples, ensuring reliable RBP4 quantification.
• Application versatility: These antibodies support ELISA kit development, Western blot analysis, and IHC, catering to both research and diagnostic needs. Their high specificity minimizes cross-reactivity, enabling accurate detection of RBP4 in complex biological matrices.

These products provide global partners with high-quality raw materials for RBP4 detection, facilitating the development of accurate diagnostic tools and advancing biomedical research.

5. Brand Mission of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. is dedicated to empowering global life science research and clinical practice through high-quality, innovative reagents and professional services. As a leading provider of life science solutions, the company offers a comprehensive portfolio including antibodies, recombinant proteins, ELISA kits, and general laboratory reagents, with three specialized sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Leveraging advanced R&D platforms—including recombinant antibody development (rabbit/mouse monoclonal), protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—ANT BIO PTE. LTD. adheres to the principles of "precision, reliability, and customer-centricity." The company strives to deliver cost-effective products and tailored support to researchers, clinicians, and biopharmaceutical partners, accelerating the translation of scientific discoveries into improved patient care and advancing global health.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.